Australia's NeuroScientific Biopharmaceuticals rises on R&D contract

Neuroscientific Biopharmaceuticals

02/11/2021 02:30

** Shares of NeuroScientific Biopharmaceuticals  NSB.AX 
rise as much 5.9% to A$0.360, marking their best session since
Oct 21
    ** NSB partners with contract research organisation
Biospective Inc for R&D of EmtinB, co's therapeutic treatment
for multiple sclerosis  urn:newsml:reuters.com:*:nFWN2RS24W
    ** More than 128,608 shares change hands, compared with the
30-day average of 218,873 shares 
    ** Stock up 36% so far this year, as of last close    


 (Reporting by Upasana Singh in Bengaluru)
 ((Upasana.Singh@thomsonreuters.com))